Newsroom

Categories: Omics & Genetics, Biotechnology, Corporate, Finance & Investor

University of Colorado grants license to Cirena for RNA-synthesis technology

March 10, 2026

Categories: Omics & Genetics, Biotechnology

Epigenica AB launches EpiFinder™ cNUC: The first platform to simultaneously profile multiple histone marks and DNA methylation directly from circulating nucleosomes in plasma and serum

February 25, 2026

Categories: Pharma, Clinical Research & Trials, Corporate, Finance & Investor

Inceptua Group appoints healthcare industry leader Kurt Hilzinger as chairman of the board

February 23, 2026

Categories: Omics & Genetics, Clinical Research & Trials, Corporate, Finance & Investor

Cirena launches high-purity long RNA to accelerate CRISPR and genome-editing research

February 3, 2026

Categories: Microscopy & Imaging, Clinical Research & Trials, Corporate, Finance & Investor

Fidēs Imaging launches next-generation imaging core lab

January 29, 2026

Categories: Bioprocessing, Omics & Genetics, Research

Epigenica launches EpiFinder™ Analysis Service, a fully managed platform for fast and reliable epigenomic insights

January 27, 2026

Categories: Healthcare, Medical Devices & Technology

Ceryx Medical (Ceryx) appoints leading MedTech executive Mark Strong as Non-Executive Director

January 26, 2026

Categories: Drug Discovery & Development, Clinical Research & Trials

Cycle Pharmaceuticals and Inceptua Group expand the Free Goods Programme for patients with Hereditary Tyrosinemia Type 1 (HT-1) and Alkaptonuria (AKU) to include Morocco and Egypt.

January 9, 2026

Categories: Healthcare, COVID-19, Clinical Research & Trials

Groundbreaking myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

December 4, 2025